Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering manganese-based immune amplifier for chemoimmunotherapy of peritoneal metastatic colorectal cancer.

Materials today. Bio·2026
Same author

Reciprocal regulation between JOSD2 and CREB1 drives aerobic glycolysis and progression of renal cell carcinoma.

Redox biology·2026
Same author

Invasion/metastasis-related differentially methylated genes predict prognosis in diffuse gliomas.

Journal of neuro-oncology·2026
Same author

Aerobic Exercise-Induced TGF-β Receptor Reprogramming Disrupts Neutrophil-Microglia Crosstalk to Attenuate Early Brain Injury after Subarachnoid Hemorrhage.

Research (Washington, D.C.)·2026
Same author

Case report: Forced walking for treating lower limb paralysis after corpus callosum injury.

Medicine·2026
Same author

Rhein-Mn coordination nanomedicine for peritoneal metastatic colorectal cancer: synergistic mitochondrial targeting, immunogenic cell death, and reverses immunosuppression.

Journal of nanobiotechnology·2026

Related Experiment Video

Updated: Jun 11, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Comprehensive Characterization of Metastatic Patterns and a Redefined Prognostic Framework in Metastatic Prostate

Shiqiang Zhang1, Yiyu Sheng1, Yiran Wang1

  • 1Department of Urology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.

The Prostate
|June 9, 2026
PubMed
Summary
This summary is machine-generated.

A new four-tier risk model for metastatic prostate cancer (mPCa) improves survival prediction. This model integrates diverse metastatic features, offering better prognostic insight than current staging methods.

Keywords:
metastatic patternsmetastatic prostate cancerprognostic stratificationrisk classification

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Related Experiment Videos

Last Updated: Jun 11, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Area of Science:

  • Oncology
  • Cancer Research
  • Urologic Oncology

Background:

  • Metastatic prostate cancer (mPCa) presents complex metastatic patterns.
  • A comprehensive evaluation of these patterns and their prognostic impact is needed.

Purpose of the Study:

  • To systematically characterize metastatic patterns in mPCa.
  • To develop and validate a novel risk stratification model for improved prognostic accuracy.

Main Methods:

  • Utilized the Surveillance, Epidemiology, and End Results (SEER) database for patient identification (n=13,325).
  • Systematically characterized metastatic patterns and estimated cancer-specific survival (CSS) and overall survival (OS).
  • Developed a four-tier risk stratification model and compared its prognostic discrimination with the conventional M classification using Harrell's C-index and AUC.

Main Results:

  • Liver-only and multiple visceral metastases were associated with significantly poorer survival.
  • The developed four-tier risk model demonstrated clear stepwise discrimination for both CSS and OS.
  • The four-tier model exhibited superior prognostic discrimination compared to the conventional M classification (higher C-index and AUC values).

Conclusions:

  • Survival outcomes in mPCa vary significantly based on metastatic patterns.
  • A simplified four-tier risk stratification model integrating multidimensional metastatic features offers incremental prognostic information.
  • Further external validation is necessary before clinical implementation of the new model.